https://ipharmag.com/article/trumprx-explained-drugs-prices-how-it-works iPharmag en 2026-09-29T00:41:17+00:00 What Is TrumpRx? How the Drug-Price Site Works, What’s on It, and Who Can Use It https://ipharmag.com/article/fda-approves-gazyva-childhood-nephrotic-syndrome-relapse iPharmag en 2026-09-29T00:41:17+00:00 First New Treatment in 70 Years: FDA Approves Gazyva to Prevent Nephrotic Syndrome Relapses https://ipharmag.com/article/fda-approves-abbvie-juvmo-tavapadon-parkinsons iPharmag en 2026-09-29T00:41:17+00:00 FDA Approves AbbVie’s Juvmo, a New Kind of Once-Daily Parkinson’s Pill https://ipharmag.com/article/retatrutide-explained-research-peptide-risks iPharmag en 2026-09-28T01:55:20+00:00 Retatrutide Explained: What the Trials Show, and Why “Research Peptide” Versions Are Risky https://ipharmag.com/article/glucosamine-supplement-linked-faster-alzheimers-progression iPharmag en 2026-09-28T01:55:20+00:00 Glucosamine, a Popular Joint Supplement, Linked to Faster Alzheimer’s Progression https://ipharmag.com/article/crispr-ctx310-one-time-gene-edit-halves-ldl-cholesterol-year iPharmag en 2026-09-28T01:55:20+00:00 A One-Time CRISPR Treatment Cut “Bad” Cholesterol in Half — and It Held for a Year